U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07001553) titled 'Understanding Acute Dietary Changes After GLP-1 Agonist Treatment: The GLaD Feasibility Study' on May 22.
Brief Summary: An observational study of those who have been prescribed a GLP-1 agonist therapy (yet to commence), for either weight or diabetes management, and are willing to complete dietary records and questionnaires of behaviour and psychosocial health.
Study Start Date: May 31
Study Type: OBSERVATIONAL
Condition:
Obesity
Type 2 Diabetes Mellitus (T2DM)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Australian Catholic University
Published by HT Digital Content Services with permission from Health Daily Digest....